Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-Risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is predictive of therapeutic response

PURPOSE: For high-risk prostate cancer, standard treatment options include radical prostatectomy (RP) or radiation therapy plus androgen-deprivation therapy (ADT). Despite definitive therapy, many patients will have disease recurrence. Imaging has the potential to better define characteristics of re...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Cancer Res
Autori principali: Karzai, Fatima, Walker, Stephanie M., Wilkinson, Scott, Madan, Ravi A., Shih, Joanna H., Merino, Maria J., Harmon, Stephanie A., VanderWeele, David J., Cordes, Lisa M., Carrabba, Nicole V., Bright, John R., Terrigino, Nicolas T., Chun, Guinevere, Bilusic, Marijo, Couvillon, Anna, Hankin, Amy, Williams, Monique N., Lis, Rosina T., Ye, Huihui, Choyke, Peter L., Gulley, James L., Sowalsky, Adam G., Turkbey, Baris, Pinto, Peter A., Dahut, William L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7855232/
https://ncbi.nlm.nih.gov/pubmed/33023952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-20-2344
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi